Crystal structure of Bak bound to the inhibitory aBAK

Computational design of potent and selective inhibitors of BAK and BAX

Apoptosis regulator BAK,Bcl-2-like protein 7,Bcl2-L-7

NRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHH
SIARWIAQRGGWVAALNLGNG

GGADPKKVLDQAKDQMENVVRTLKQELEELAKEARKLDLTQSEKIELKLRYIVAHLAAIGDIEEAIREAKEEADKLKRAG
LVNSQQFDEFKRRLEELHKEADRKRADYAEEFRNKLEYG

0.1 M 2-(N-Morpholino)ethanesulfonic acid (MES) pH 6.5, 0.2 M L-Proline and 10% (w/v) polyethylene glycol (PEG) 3350

National Health and Medical Research Council (NHMRC, Australia)

BAK, inhibitor, BH3-mimetic, computational design, APOPTOSIS

(chain A and (resid 86 through 135 or resid 137 through 164 or (resid 165 and (name N or name CA or name C or name O or name CB ))))

(chain C and (resid 86 through 135 or resid 137 through 165))

(chain E and (resid 86 through 135 or resid 137 through 164 or (resid 165 and (name N or name CA or name C or name O or name CB ))))

(chain G and (resid 86 through 135 or resid 137 through 165))

(chain B and ((resid 2 through 3 and (name N or name CA or name C or name O or name CB )) or resid 4 through 113 or (resid 114 and (name N or name CA or name C or name O or name CB ))))

(chain D and ((resid 2 through 3 and (name N or name CA or name C or name O or name CB )) or resid 4 through 114))

(chain F and ((resid 2 through 3 and (name N or name CA or name C or name O or name CB )) or resid 4 through 113 or (resid 114 and (name N or name CA or name C or name O or name CB ))))

NRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHH
CIARWIAQRGGWVAALNLGNG